Literature DB >> 19322684

[Genetics and Alzheimer's disease].

S Manzano, J L González, A Marcos, J Matías-Guiu.   

Abstract

INTRODUCTION: Alzheimer's disease (AD) is the first cause of dementia (60-80%). The causal genes with autosomal dominant inheritance in the early onset forms (APP, PSEN-1, PSEN-2) and one susceptibility gene in the late onset forms (APOE) are described. DEVELOPMENT: Causal genes involved in the early onset forms account for approximately 5% of the total. Among all the susceptibility genes, only the APOE gene, involved in the late onset forms, has been replicated in all the studies. However, it has not been possible to replicate the more than 200 genes in family or case-control studies. Nonetheless, the genetics of Alzheimer's disease is very complex. The models that have the most influence in its most frequent phenotypes are multifactorial ones (genetics and environmental ones).
CONCLUSIONS: AD is a disease with a complex inheritance. The early onset forms have supposed a great advance in the knowledge of the ethiopathogeny of the disease. However, especially valuable information could be extrapolated from knowledge on the late onset forms given its similarities with the most prevalence forms, that is, the sporadic ones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322684

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  3 in total

Review 1.  Pathological implications of cell cycle re-entry in Alzheimer disease.

Authors:  David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Expert Rev Mol Med       Date:  2010-06-29       Impact factor: 5.600

Review 2.  Review: cell cycle aberrations and neurodegeneration.

Authors:  D J Bonda; V P Bajić; B Spremo-Potparevic; G Casadesus; X Zhu; M A Smith; H-G Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2010-01-06       Impact factor: 8.090

Review 3.  Epigenetic approaches to psychiatric disorders.

Authors:  Carolyn Ptak; Arturas Petronis
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.